Cord blood: The future of regenerative medicine?

Reproductive BioMedicine Online

Volumn 20, Issue 1, 2010, Pages 98-102

  Seres, K B ^a   Hollands, P ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Cord blood; Regenerative medicine; Stem cells

Indexed keywords

CD34 ANTIGEN; CYTOKINE;

ANEMIA; ANGIOGENESIS; ARTICLE; BIOREACTOR; BLOOD DISEASE; BLOOD TRANSFUSION; BONE DEVELOPMENT; BUERGER DISEASE; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CHELATION; CONNECTIVE TISSUE; CORD BLOOD STEM CELL TRANSPLANTATION; DEGENERATIVE DISEASE; DIABETIC NEUROPATHY; EAR CARTILAGE; EMBRYO; EMBRYONIC STEM CELL; ENDOCRINE CELL; ENGRAFTMENT; EX VIVO STUDY; HEART INFARCTION; HEMATOPOIESIS; HEMOGLOBINOPATHY; HUMAN; HUMAN CELL; LEPROSY; LEUKEMIA; MESENCHYMAL STEM CELL; MYELOID PROGENITOR CELL; NEOVASCULARIZATION (PATHOLOGY); NERVE CELL; NON INVASIVE PROCEDURE; OSTEOARTHRITIS; PARKINSON DISEASE; REGENERATIVE MEDICINE; RHEUMATOID ARTHRITIS; STROKE; SYSTEMIC CIRCULATION; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 77149125240     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.10.012     Document Type: Article

References (60)

1. Aggarwal, S., Pittenger, M.F., 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822.
2. Amariglio, N., Hirshberg, A., Scheithauer, B.W., et al., 2009. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 6, e1000029.
3. Barker, J.N., Weisdorf, D.J., DeFor, T.E., et al., 2003. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102, 1915-1919.
4. Barker, J.N., Weisdorf, D.J., DeFor, T.E., et al., 2005. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105, 1343-1347.
5. Bhattacharya, N., 2006a. Transient spontaneous engraftment of CD34+ hematopoietic cord blood stem cells as seen in peripheral blood: treatment of leprosy patients with anemia by placental umbilical cord whole blood transfusion. Clin. Exp. Obstet. Gynecol. 33, 159-163.
6. Bhattacharya, N., 2006b. A preliminary report of 123 units of placental umbilical cord whole blood transfusion in HIV-positive patients with anemia and emaciation. Clin. Exp. Obstet. Gynecol. 33, 117-121.
7. Bhattacharya, N., 2006c. A study of placental umbilical cord whole blood transfusion in 72 patients with anemia and emaciation in the background of cancer. Eur. J. Gynaecol. Oncol. 27, 155-161.
8. Borlongan, C.V., 2009. Cell therapy for stroke: remaining issues to address before embarking on clinical trials. Stroke 40, S146-S148.
9. Chaudhuri, A., Hollands, P., Bhattacharya, N., 2007. Placental umbilical cord blood transfusion in acute ischaemic stroke. Med. Hypotheses 69, 1267-1271.
10. Chen, N., Hudson, J.E., Walczak, P., et al., 2005. Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells (Dayton, Ohio) 23, 1560-1570.
11. Dimmeler, S., Zeiher, A.M., Schneider, M.D., 2005. Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest. 115, 572-583.
12. Djouad, F., Plence, P., Bony, C., et al., 2003. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 3837-3844.
13. Ehring, B., Biber, K., Upton, T.M., et al., 2003. Expansion of HPCs from cord blood in a novel 3D matrix. Cytotherapy 5, 490-499.
14. Finney, M.R., Greco, N.J., Haynesworth, S.E., et al., 2006. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biology of Blood and Marrow Transplantation. J. Am. Soc. Blood Marrow Transplant. 12, 585-593.
15. Freed, C.R., Greene, P.E., Breeze, R.E., et al., 2001. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710-719.
16. Fuchs, J.R., Hannouche, D., Terada, S., et al., 2005. Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells. Stem Cells (Dayton, Ohio) 23, 958-964.
17. Fukuda, H., Masuzaki, H., Ishimaru, T., 2002. Interleukin-6 and interleukin-1 receptor antagonist in amniotic fluid and cord blood in patients with pre-term, premature rupture of the membranes. Int. J. Gynaecol. Obstet. 77, 123-129.
18. Gang, E.J., Hong, S.H., Jeong, J.A., et al., 2004. In-vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 321, 102-108.
19. Gao, F., Wu, D.Q., Hu, Y.H., et al., 2008. In-vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transi. Res.: J. Lab. Clin. Med. 151, 293-302.
20. Gluckman, E., Broxmeyer, H.A., Auerbach, A.D., et al., 1989. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174-1178.
21. Hess, D.C., Borlongan, C.V., 2008. Cell-based therapy in ischemic stroke. Expert Rev. Neurother. 8, 1193-1201.
22. Hollands, P., 2009. Cord blood stem cells - the basic science. In: Bhattacharya, N., Stubblefield, P. (Eds.), Frontiers of Cord Blood Science. Springer-Verlag, London, pp. 19-25.
23. Hong, S.H., Gang, E.J., Jeong, J.A., et al., 2005. In-vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem. Biophys. Res. Commun. 330, 1153-1161.
24. Hutson, E.L., Boyer, S., Genever, P.G., 2005. Rapid isolation, expansion, and differentiation of osteoprogenitors from full-term umbilical cord blood. Tissue Eng. 11, 1407-1420.
25. Ishikawa, F., Yasukawa, M., Yoshida, S., et al., 2004. Human cord blood- and bone marrow-derived CD34+ cells regenerate gastro-intestinal epithelial cells. FASEB J. 18, 1958-1960.
26. Kakinuma, S., Asahina, K., Okamura, K., et al., 2007. Human cord blood cells transplanted into chronically damaged liver exhibit similar characteristics to functional hepatocytes. Transplant. Proc. 39, 240-243.
27. Kim, S.W., Han, H., Chae, G.T., et al., 2006. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells (Dayton, Ohio) 24, 1620-1626.
28. Krampera, M., Pasini, A., Pizzolo, G., et al., 2006. Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr. Opin. Pharmacol. 6, 435-441.
29. Laughlin, M.J., Eapen, M., Rubinstein, P., et al., 2004. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N. Engl. J. Med. 351, 2265-2275.
30. Laurencin, C.T., Ambrosio, A.M., Borden, M.D., et al., 1999. Tissue engineering: orthopedic applications. Annu. Rev. Biomed. Eng. 1, 19-46.
31. Le Blanc, K., Tammik, C., Rosendahl, K., et al., 2003a. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31, 890-896.
32. Le Blanc, K., Tammik, L., Sundberg, B., et al., 2003b. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57, 11-20.
33. Lee, S.T., Jang, J.H., Cheong, J.W., et al., 2002. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br. J. Haematol. 118, 1128-1131.
34. Lee, K.D., Kuo, T.K., Whang-Peng, J., et al., 2004. In-vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40, 1256-1259.
35. Lewis, I.D., Almeida-Porada, G., Du, J., et al., 2001. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 97, 3441-3449.
36. Liu, C.H., Hwang, S.M., 2005. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32, 270-279.
37. Loomans, C.J., de Koning, E.J., Staal, F.J., et al., 2004. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53, 195-199.
38. Lu, L.L., Liu, Y.J., Yang, S.G., et al., 2006. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91, 1017-1026.
39. McGuckin, C., Jurga, M., Ali, H., et al., 2008. Culture of embryonic-like stem cells from human umbilical cord blood and onward differentiation to neural cells in vitro. Nat. Protoc. 3, 1046-1055.
40. McNiece, I., Kubegov, D., Kerzic, P., et al., 2000. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp. Hematol. 28, 1181-1186.
41. Murohara, T., 2001. Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends Cardiovasc. Med. 11, 303-307.
42. Nagano, M., Yamashita, T., Hamada, H., et al., 2007. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 110, 151-160.
43. Naruse, K., Nakashima, E., Hamada, Y., et al., 2005. Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 54, 1823-1828.
44. Niemeyer, P., Seckinger, A., Simank, H.G., et al., 2004. Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in-vitro study. Der. Orthopade 33, 1346-1353.
45. Noel, D., Gazit, D., Bouquet, C., et al., 2004. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells (Dayton, Ohio) 22, 74-85.
46. Park, D.H., Borlongan, C.V., Eve, D.J., et al., 2008. The emerging field of cell and tissue engineering. Med. Sci. Monit. 14, RA206-RA220.
47. Park, D.H., Borlongan, C.V., Willing, A.E., et al., 2009. Human umbilical cord blood cell grafts for stroke. Cell Transplant., pii: CT-2067 [e-publication ahead of print].
48. Peled, T., Mandel, J., Goudsmid, R.N., et al., 2004. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy 6, 344-355.
49. Rocha, V., Labopin, M., Sanz, G., et al., 2004. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl. J. Med. 351, 2276-2285.
50. Sanberg, P.R., Willing, A.E., Garbuzova-Davis, S., et al., 2005. Umbilical cord blood-derived stem cells and brain repair. Ann. N. Y. Acad. Sci. 1049, 67-83.
51. Schmidt, D., Breymann, C., Weber, A., et al., 2004. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann. Thorac. Surg. 78, 2094-2098.
52. Shin, J.W., Lee, D.W., Kim, M.J., et al., 2005. Isolation of endothelial progenitor cells from cord blood and induction of differentiation by ex vivo expansion. Yonsei Med. J. 46, 260-267.
53. Szabolcs, P., Park, K.D., Reese, M., et al., 2003. Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp. Hematol. 31, 708-714.
54. Vats, A., Tolley, N.S., Polak, J.M., et al., 2002. Stem cells: sources and applications. Clin. Otolaryngol. Allied Sci. 27, 227-232.
55. Vendrame, M., Gemma, C., de Mesquita, D., et al., 2005. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 14, 595-604.
56. Ye, Z.Q., Burkholder, J.K., Qiu, P., et al., 1994. Establishment of an adherent cell feeder layer from human umbilical cord blood for support of long-term hematopoietic progenitor cell growth. Proc. Natl Acad. Sci. USA 91, 12140-12144.
57. Yoshida, S., Ishikawa, F., Kawano, N., et al., 2005. Human cord blood-derived cells generate insulin-producing cells in vivo. Stem Cells (Dayton, Ohio) 23, 1409-1416.
58. Yu, G., Borlongan, C.V., Stahl, C.E., et al., 2009. Systemic delivery of umbilical cord blood cells for stroke therapy: a review. Restor. Neurol. Neurosci. 27, 41-54.
59. Yu, Y., Ren, H., Yun, W., et al., 2008. Differentiation of human umbilical cord blood-derived mesenchymal stem cells into chondroblast and osteoblasts. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 25, 1385-1389.
60. Zhao, R.C., Liao, L., Han, Q., 2004. Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. J. Lab. Clin. Med. 143, 284-291.